Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Biallelic loss-of-function variants in ADA2 (CECR1) have been identified in patients presenting with congenital hypoplastic anemia clinically consistent with Diamond-Blackfan anemia. Initially, a 6-year-old boy with transfusion-dependent anemia and absent bone marrow erythroid precursors was found to harbor compound heterozygous ADA2 variants after whole-genome sequencing (c.336C>G (p.His112Gln) and an intragenic deletion) and decreased ADA2 activity, following negative testing for classical DBA genes (PMID:30559313). Subsequently, in a series of 24 DADA2 patients, nine individuals exhibited a DBA-like pure red cell aplasia phenotype and were confirmed to carry biallelic ADA2 variants (PMID:31043544), yielding ten unrelated probands with autosomal recessive inheritance and confirmed parental carrier segregation.
Transcriptomic profiling of proerythroblasts from patients with RPS19 or CECR1 mutations showed a shared signature of impaired erythroid differentiation and upregulation of stress-response genes. Colony-forming unit-erythroid assays demonstrated failure of erythroid maturation in CECR1-mutated cells, mirroring classical DBA phenotypes (PMID:34177624). This concordant functional evidence supports a loss-of-function mechanism for ADA2 in erythropoiesis. No conflicting evidence has been reported. Although evidence is currently limited, ADA2 should be considered in genetically unsolved DBA cases.
Key Take-home: ADA2 deficiency constitutes a non-ribosomal, autosomal recessive cause of Diamond-Blackfan-like congenital hypoplastic anemia, meriting inclusion in diagnostic genomic panels.
Gene–Disease AssociationLimitedTen unrelated probands with biallelic ADA2 variants presenting with DBA-like congenital hypoplastic anemia; AR inheritance with parental carrier segregation. Genetic EvidenceLimitedAutosomal recessive compound heterozygous or homozygous ADA2 variants in 10 probands; no extended familial segregation beyond parental carriers. Functional EvidenceLimitedShared proerythroblast transcriptomic signature with RPS19 DBA and erythroid differentiation failure in CFU-E assays in CECR1-mutated samples. |